The HH genotype of the non-conservative amino acid substitution polymorphism N372H in the BRCA2 gene was reported to be associated with a 1.3-fold to 1.5-fold increase in the risk of both breast and ovarian cancer [15-18], but there have been negative studies as well [19,20]. The gene discussed is BRCA2; the disease is ovarian carcinoma.